English
Spanish
French
German
Italian
Chinese (Simplified)
Japanese
Korean
Arabic
Portuguese
Molnunat 200mg Capsule
Product Details:
- Drug Type Health Supplements
- Ingredients Molnupiravir (200mg)
- Physical Form Tablets
- Dosage As Directed by the Physician
- Dosage Guidelines Warning: keep out of the reach and sight of children and away from pets, never share your medicines with others, and use this medication only for the indication prescribed. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects.
- Suitable For Children Teenagers Women Adults Aged Person Suitable For All
- Storage Instructions Store below 30C
- Click to View more
Molnunat 200mg Capsule Price And Quantity
- 1 Bottle
- 1600 INR/Bottle
Molnunat 200mg Capsule Product Specifications
- Health Supplements
- Store below 30C
- As Directed by the Physician
- Children Teenagers Women Adults Aged Person Suitable For All
- Tablets
- Molnupiravir (200mg)
- Warning: keep out of the reach and sight of children and away from pets, never share your medicines with others, and use this medication only for the indication prescribed. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects.
Molnunat 200mg Capsule Trade Information
- Cash on Delivery (COD) Cash Advance (CA) Cash in Advance (CID) Telegraphic Transfer (T/T)
- 20 Bottle Per Day
- 7 Days
- Asia Australia Central America North America South America Eastern Europe Western Europe Middle East Africa
- All India
Product Description
Molnunat 200mg Capsule is the first oral antiviral medication that helps treat mild to moderate COVID 19 in adults. It prevents the virus from multiplying, thereby reducing viral load and disease severity. The drug received emergency use approval from Indian drug regulatory authorities on December 28, 2021.
Molnunat 200mg Capsule is only indicated in patients with mild to moderate COVID-19 symptoms and who have a high risk of developing severe symptoms. The risk factors include obesity, older age (60 years), diabetes mellitus, and heart diseases. It is not indicated in patients who require immediate hospitalization due to COVID-19. This drug has also been approved by the U.S. Food and Drug Administration (FDA) and the UK regulatory agency for emergency use.
Warning: Molnunat keep out of the reach and sight of children and away from pets, never share your medicines with others, and use this medication only for the indication prescribed.
The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects.
Other Products in 'Oncology Tablets' category
Delhi, India
Send Inquiry
 |
MODERN TIMES HELP LINES PHARMA
All Rights Reserved.(Terms of Use) Developed and Managed by Infocom Network Private Limited. |